Search Results

Cetirizine [Zyrtec, Zyrtec-D 12 Hour; McNeil Consumer Healthcare] is now available over the counter in the US for perennial and seasonal allergic rhinitis.

Source: Inpharma, Volume 1, Number 1623, 2008-02-02 , pp. 18-18(1)

Publisher: Adis International

Merck & Co has received a not approvable letter for its New Drug Application for OTC lovastatin [Mevacor OTC] 20mg from the US FDA.

Source: Inpharma, Volume 1, Number 1623, 2008-02-02 , pp. 18-18(1)

Publisher: Adis International

Some OTC earwax softeners like trolamine [Cerumenex] can cause severe inflammation and damage to the inner ear and eardrum

Source: Reactions, Volume 1, Number 1188, 2008-02-09 , pp. 4-4(1)

Publisher: Adis International

Some OTC earwax softeners like trolamine [Cerumenex] can cause severe inflammation and damage to the inner ear and eardrum

Source: Inpharma, Volume 1, Number 1624, 2008-02-09 , pp. 21-21(1)

Publisher: Adis International

Chattem has issued a voluntary nationwide recall of Icy Hot Heat Therapy products in the US following reports of first, second and third degree burns

Source: Reactions, Volume 1, Number 1189, 2008-02-16 , pp. 3-3(1)

Publisher: Adis International

Perrigo Company's Abbreviated New Drug Application for OTC chewable famotidine/calcium carbonate/magnesium hydroxide tablets

Source: Inpharma, Volume 1, Number 1625, 2008-02-16 , pp. 22-22(1)

Publisher: Adis International

The US FDA has approved cetirizine chewable tablets [Caraco Pharmaceuticals] for allergic inflammatory conditions.

Source: Inpharma, Volume 1, Number 1621, 2008-01-19 , pp. 23-23(1)

Publisher: Adis International

Warnings issued against OTC cough and cold medicines in kids

Source: Reactions, Volume 1, Number 1186, 2008-01-26 , pp. 2-2(1)

Publisher: Adis International

GlaxoSmithKline's Alli [orlistat] and Lily/Amylin's Byetta [exenatide] are making impacts in the obesity drug market

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 543, 2007-12-15 , pp. 11-11(1)

Publisher: Adis International

Benefits and risks of antiobesity drugs weighed up

Source: Inpharma, Volume 1, Number 1616, 2007-12-01 , pp. 21-21(1)

Publisher: Adis International

Recommendations for OTC cough/cold drugs in infants

Source: Reactions, Volume 1, Number 1174, 2007-10-20 , pp. 1-1(1)

Publisher: Adis International

The UK MHRA has announced that products containing pseudoephedrine or ephedrine will retain OTC status

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 536, 2007-09-08 , pp. 11-11(1)

Publisher: Adis International

The US Nonprescription Drugs Advisory Committee will discuss the safety and efficacy of cough and cold drug products in children

Source: Reactions, Volume 1, Number 1166, 2007-08-25 , pp. 2-2(1)

Publisher: Adis International

Scopolamine hydrobromide: First report of oesophagitis: case report

Source: Reactions, Volume 1, Number 1159, 2007-07-07 , pp. 26-26(1)

Publisher: Adis International

Tetryzoline: Amnesia (first report) and consciousness disorders: 5 case reports

Source: Reactions, Volume 1, Number 1159, 2007-07-07 , pp. 29-29(1)

Publisher: Adis International

Methyl salicylate overdose: Death: case report

Source: Reactions, Volume 1, Number 1157, 2007-06-23 , pp. 19-19(1)

Publisher: Adis International

Aluminum hydroxide/calcium carbonate/magnesium hydroxide: Milk-alkali syndrome (first report with magnesium hydroxide) in an elderly patient: case report

Source: Reactions, Volume 1, Number 1155, 2007-06-09 , pp. 6-7(2)

Publisher: Adis International

Anecdotal evidence of increasing OTC drug dependency

Source: Reactions, Volume 1, Number 1151, 2007-05-12 , pp. 4-4(1)

Publisher: Adis International

Anecdotal evidence of increasing OTC drug dependency

Source: Inpharma, Volume 1, Number 1587, 2007-05-12 , pp. 22-22(1)

Publisher: Adis International

Auriga Laboratories has launched its zinc formulation [Zinx] in the US for the treatment of the common cold.

Source: Inpharma, Volume 1, Number 1579, 2007-03-17 , pp. 23-23(1)

Publisher: Adis International